# Apimeds Pharmaceuticals US, Inc. Posts $2.89 Million Revenue and $7.68 Diluted GAAP EPS

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/60504
Published: 2026-11-18T14:11:15.000Z
Updated: 2026-11-18T14:11:15.000Z
Section: Business

> Third-quarter basic GAAP EPS was $19.13.

Apimeds Pharmaceuticals US, Inc. recorded $2.89 million in third-quarter revenue, with basic GAAP EPS of $19.13 and diluted GAAP EPS of $7.68.


